AIT Therapeutics Inc Share Price OTC Bulletin Board
Equities
Medical Equipment, Supplies & Distribution
Sales 2024 * | 14.38L 12Cr | Sales 2025 * | 1.32Cr 110.12Cr | Capitalization | 5.14Cr 428.98Cr |
---|---|---|---|---|---|
Net income 2024 * | -6.2Cr -517.39Cr | Net income 2025 * | -6.4Cr -534.08Cr | EV / Sales 2024 * | 27.3 x |
Net cash position 2024 * | 1.21Cr 101.38Cr | Net Debt 2025 * | 29.5L 25Cr | EV / Sales 2025 * | 4.12 x |
P/E ratio 2024 * |
-0.58
x | P/E ratio 2025 * |
-0.64
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.02% |
Latest transcript on AIT Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Steven Lisi
CEO | Chief Executive Officer | 53 | 13/17/13 |
Douglas Larson
DFI | Director of Finance/CFO | 53 | 01/21/01 |
Amir Avniel
PSD | President | 50 | 13/17/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Bentsur
BRD | Director/Board Member | 58 | 01/15/01 |
William Forbes
BRD | Director/Board Member | 62 | 13/18/13 |
Erick Lucera
BRD | Director/Board Member | 57 | 10/17/10 |
1st Jan change | Capi. | |
---|---|---|
-5.48% | 18TCr | |
+2.10% | 11TCr | |
-3.31% | 6.85TCr | |
+0.77% | 4.97TCr | |
+7.98% | 4.45TCr | |
+2.33% | 4.07TCr | |
+22.59% | 3.12TCr | |
+1.86% | 2.61TCr | |
+15.30% | 2.53TCr |